SAN FRANCISCO--(BUSINESS WIRE)--The robotic cell therapy manufacturing Consortium founded by Multiply Labs, with initial participation from UCSF and Cytiva, announced today that Thermo Fisher ...
Multiply Labs, a San Francisco-based robotics company developing advanced automated manufacturing systems for cell therapies, announced an expansion of its collaboration with Thermo Fisher Scientific.
Multiply Labs collaborated with these life science industry leaders to demonstrate automated cell therapy manufacturing tasks, with an emphasis on cell expansion. The results of the proof-of-concept ...
Automating Thermo Fisher’s cutting-edge, GMP-ready instruments using Multiply Labs’ robotic technology helps reduce costs and accelerates timelines, bringing cell therapy scalability and accessibility ...